Sun Pharmaceutical Industries Ltd: Announces Q4 & FY11 results

Sun Pharmaceutical Industries Ltd has announced the following results for the quarter & year ended March 31, 2011:

The Unaudited results for the Quarter ended March 31, 2011

The Company has posted a net profit after tax of Rs 3727.80 million for the quarter ended March 31, 2011 as compared to Rs 2560.40 million for the quarter ended March 31, 2010. Total Income has increased from Rs 7048.50 million for the quarter ended March 31, 2010 to Rs 8285.60 million for the quarter ended March 31, 2011.

The Audited results for the Year ended March 31, 2011

The Company has posted a net profit after tax of Rs 13838.00 million for the year ended March 31, 2011 as compared to Rs 8986.50 million for the year ended March 31, 2010. Total Income has increased from Rs 24706.30 million for the year ended March 31, 2010 to Rs 31757.80 million for the year ended March 31, 2011.

"The Consolidated Results are as follows :

The Unaudited consolidated results for the Quarter ended March 31, 2011

The Group has posted a net profit after minority interest of Rs 4427.50 million for the quarter ended March 31, 2011 where as the same was at Rs 3944.70 million for the quarter ended March 31, 2010. Total Income is Rs 15292.10 million for the quarter ended March 31, 2011 where as the same was at Rs 10689.50 million for the quarter ended March 31, 2010.

The Audited consolidated results for the Year ended March 31, 2011

The Group has posted a net profit after minority interest of Rs 18160.60 million for the year ended March 31, 2011 where as the same was at Rs 13510.80 million for the year ended March 31, 2010. Total Income is Rs 58599.80 million for the year ended March 31, 2011 where as the same was at Rs 40989.00 million for the year ended March 31, 2010."

Taro Pharmaceutical Industries Ltd (Taro), a pharmaceutical company, incorporated in Israel became a subsidiary of the Company on September 20, 2010. Accordingly, the above results for the current periods includes the relevant results of Taro and its subsidiaries from the date Taro became subsidiary of the Company and therefore the corresponding figures for the previous periods are not comparable.Read More